In the “GP only” profile, the proportion of participants with a duration of diabetes >10 years (37.0%) and using insulin or other injectable (22.6%) was lower than in other profiles (51.0% to 61.6%, and 63.5% to 75.0%, respectively). This evidence concerns the gene INS and diabetes mellitus.